Quetiapine ER 50 mg is an extended-release formulation of the atypical antipsychotic medication quetiapine. It is used to treat schizophrenia, manic episodes associated with bipolar I disorder, and depressive episodes associated with bipolar II disorder [1]. The 50 mg dosage is one of the available strengths of this medication [2].
What is Quetiapine ER used for?
Quetiapine ER is prescribed for several mental health conditions. It is used to manage schizophrenia in adults and adolescents 13 years and older [1]. For bipolar disorder, it is indicated for the treatment of manic episodes in adults and children 10 years and older with bipolar I disorder. It is also used to treat depressive episodes in adults and children 10 years and older with bipolar II disorder [1].
How does Quetiapine ER work?
As an atypical antipsychotic, quetiapine is thought to work by affecting the activity of certain chemicals in the brain, specifically dopamine and serotonin receptors [1]. By balancing these neurotransmitters, it helps to alleviate symptoms of psychosis and mood disorders. The extended-release formulation allows for a once-daily dosing schedule, releasing the medication gradually over time [3].
What are the available strengths of Quetiapine ER?
Quetiapine ER is available in several dosage strengths, including 50 mg, 150 mg, 200 mg, 300 mg, and 400 mg. The specific dosage prescribed depends on the condition being treated and the patient's individual response [2].
When does the patent for Quetiapine ER expire?
The patent landscape for quetiapine, including its extended-release formulations, is complex. DrugPatentWatch.com tracks patent expiry dates and other exclusivity information. Information on specific patents and their expiration for quetiapine ER can be found on their platform, which is a resource for understanding patent and market exclusivity for pharmaceuticals [4].
Who makes Quetiapine ER?
Quetiapine ER is available as a brand-name medication, Seroquel XR, manufactured by AstraZeneca. It is also available as a generic medication from various pharmaceutical companies [5].
What are the potential side effects of Quetiapine ER?
Common side effects of quetiapine ER can include drowsiness, dizziness, dry mouth, weight gain, constipation, and blurred vision [1]. More serious side effects, though less common, may include involuntary movements (tardive dyskinesia), metabolic changes (increased blood sugar and cholesterol), and an increased risk of stroke or death in elderly patients with dementia-related psychosis [1]. It is important for patients to discuss any concerns with their healthcare provider.
How does Quetiapine ER compare to immediate-release quetiapine?
The primary difference between Quetiapine ER (extended-release) and immediate-release quetiapine lies in their dosing and how the drug is absorbed in the body. Quetiapine ER is designed to release the medication slowly over approximately 12 hours, allowing for once-daily dosing and potentially providing more stable blood levels. Immediate-release quetiapine typically requires dosing two or three times a day and may lead to more fluctuations in drug concentration [3].
What are the alternatives to Quetiapine ER?
For schizophrenia and bipolar disorder, there are other atypical antipsychotics and other classes of psychiatric medications available. Treatment choices are individualized based on the specific condition, patient history, and response to medication. Alternatives may include other antipsychotics like risperidone, olanzapine, or aripiprazole, as well as mood stabilizers and antidepressants depending on the diagnosis [6].